Search results for "Alcohol"

showing 10 items of 1798 documents

The role of water in the photocatalytic degradation of acetonitrile and toluene in gas-solid and liquid-solid regimes

2006

Photocatalytic degradation of acetonitrile and toluene was carried out both in gas-solid and in liquid-solid regimes by using commercialTiO2samples (Merck and Degussa P25). The investigation was mainly aimed to study the influence of water present in the reaction environment on the mechanism and degradation rate of two probe molecules. In gas-solid regime, the reacting mixture consisted of toluene or acetonitrile, oxygen, nitrogen, and water vapour. The main degradation product of toluene wasCO2with small amounts of benzaldehyde. In the presence of water vapour, the activity ofTiO2Merck remained stable but greatly decreased if water was absent.TiO2Degussa P25 continuously deactivated, even …

Muconic acidADSORPTIONBENZENEInorganic chemistrylcsh:TJ807-830lcsh:Renewable energy sourcesHUMIDIFIED AIRANATASE TIO2 CATALYSTOXIDATIONCH3CNBenzaldehydechemistry.chemical_compoundGeneral Materials ScienceFORMALDEHYDEBenzenePhotodegradationAcetonitrileBenzoic acidTITANIUM-DIOXIDERenewable Energy Sustainability and the EnvironmentGeneral ChemistryVAPOR-PHASETolueneAtomic and Molecular Physics and OpticsANATASE TIO2 CATALYST; TITANIUM-DIOXIDE; HUMIDIFIED AIR; VAPOR-PHASE; OXIDATION; ADSORPTION; BENZENE; CH3CN; FORMALDEHYDE; BEHAVIORchemistryBenzyl alcoholBEHAVIORInternational Journal of Photoenergy
researchProduct

Los trastornos oculares del espectro alcohólico fetal

2020

Este artículo se encuentra disponible en la siguiente URL: https://www.elsevier.es/es-revista-archivos-sociedad-espanola-oftalmologia-296-articulo-los-trastornos-oculares-del-espectro-S0365669119303508 Preprint

Mujeres embarazadas - Consumo de alcohol - Factores de riesgo.business.industryFetal alcohol syndrome.Eye - Diseases.Fetus - Effect of drugs on.OphthalmologyFeto - Efectos de las drogas.Embarazo - Complicaciones y secuelas.Ojos - Enfermedades.MedicinePregnant women - Alcohol use - Risk factors.Síndrome alcohólico fetal.Pregnancy - Complications.businessArchivos de la Sociedad Española de Oftalmología
researchProduct

A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease

2021

AbstractExercise and diet are treatments for nonalcoholic fatty liver disease (NAFLD) and prediabetes, however, how exercise and diet interventions impact gut microbiota in patients is incompletely understood. We previously reported a 8.6-month, four-arm (Aerobic exercise, n = 29; Diet, n = 28; Aerobic exercise + Diet, n = 29; No intervention, n = 29) randomized, singe blinded (for researchers), and controlled intervention in patients with NAFLD and prediabetes to assess the effect of interventions on the primary outcomes of liver fat content and glucose metabolism. Here we report the third primary outcome of the trial—gut microbiota composition—in participants who completed the trial (22 i…

MultidisciplinaryMicrobiotasuolistomikrobistoGeneral Physics and AstronomyGeneral Chemistryinterventiotutkimussatunnaistetut vertailukokeetGeneral Biochemistry Genetics and Molecular BiologyDietPrediabetic StateLiverNon-alcoholic Fatty Liver Diseaseei-alkoholiperäinen rasvamaksasairausHumansExerciseravitsemushoitoliikuntahoito
researchProduct

Liquid–liquid equilibria of the systems dipropyl ether+n-propanol+water and dipropyl ether+n-propanol+ethylene glycol at different temperatures

2007

Abstract In this work, experimental liquid–liquid equilibria (LLE) data of the dipropyl ether + n-propanol + water and dipropyl ether + n-propanol + ethylene glycol systems are presented. The LLE of both systems have been measured at 283.15 and 323.15 K. The equilibrium data presented are correlated using NRTL and UNIQUAC equations. The reliability of these models is tested by comparison with experimental results. Moreover, the solvent capabilities of water and ethylene glycol were compared, concluding that ethylene glycol is the best solvent to extract n-propanol.

N-PropanolUNIQUACChemistryGeneral Chemical EngineeringGeneral Physics and AstronomyAlcoholEtherPropanolSolventchemistry.chemical_compoundNon-random two-liquid modelOrganic chemistryPhysical chemistryPhysical and Theoretical ChemistryEthylene glycolFluid Phase Equilibria
researchProduct

1-n-Butyl-3-methylimidazolium-2-carboxylate: a versatile precatalyst for the ring-opening polymerization of ε-caprolactone and rac-lactide under solv…

2013

The ring-opening polymerization of ε-caprolactone (ε-CL) and rac-lactide (rac-LA) under solvent-free conditions and using 1-n-butyl-3-methylimidazolium-2-carboxylate (BMIM-2-CO2) as precatalyst is described. Linear and star-branched polyesters were synthesized by successive use of benzyl alcohol, ethylene glycol, glycerol and pentaerythritol as initiator alcohols, and the products were fully characterized by 1H and 13C{1H} NMR spectroscopy, gel permeation chromatography (GPC), and differential scanning calorimetry (DSC). BMIM-2-CO2 acts as an N-heterocyclic carbene precursor, resulting from in situ decarboxylation, either by heating under vacuo (method A) or by addition of NaBPh4 (method B)…

N-heterocarbene precursorLactideLetterOrganic ChemistryRing-opening polymerizationPentaerythritollcsh:QD241-441chemistry.chemical_compoundChemistryimidazolium-2-carboxylateschemistryPolymerizationlcsh:Organic chemistryBenzyl alcoholgreen polymerization reactionPolymer chemistryaliphatic polyestersOrganic chemistrylcsh:QorganocatalysisCarboxylatelcsh:ScienceCaprolactoneEthylene glycolBeilstein Journal of Organic Chemistry
researchProduct

Ethanol cycle in an ethanologenic bacterium

2002

AbstractA novel redox cycle is suggested, performing interconversion between acetaldehyde and ethanol in aerobically growing ethanologenic bacterium Zymomonas mobilis. It is formed by the two alcohol dehydrogenase (ADH) isoenzymes simultaneously catalyzing opposite reactions. ADH I is catalyzing acetaldehyde reduction. The local reactant ratio at its active site probably is shifted towards ethanol synthesis due to direct channeling of NADH from glycolysis. ADH II is oxidizing ethanol. The net result of the cycle operation is NADH shuttling from glycolysis to the membrane respiratory chain, and ensuring flexible distribution of reducing equivalents between the ADH reaction and respiration.

NADH channelingBiophysicsRespiratory chainBiochemistryZymomonas mobilischemistry.chemical_compoundStructural BiologyGeneticsGlycolysisEthanol metabolismMolecular BiologyAlcohol dehydrogenaseZymomonasEthanolEthanolbiologyFutile cycleRespirationZymomonas mobilisAlcohol dehydrogenaseAcetaldehydeCell BiologyNADbiology.organism_classificationAerobiosisIsoenzymeschemistryBiochemistryFutile cycleChemostatbiology.proteinOxidation-Reductionhormones hormone substitutes and hormone antagonistsFEBS Letters
researchProduct

The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care

2020

Background & Aims NAFLD is a growing health concern. The aim of the Fatty Liver Assessment in Germany (FLAG) study was to assess disease burden and provide data on the standard of care from secondary care. Methods The FLAG study is an observational real-world study in patients with NAFLD enrolled at 13 centres across Germany. Severity of disease was assessed by non-invasive surrogate scores and data recorded at baseline and 12 months. Results In this study, 507 patients (mean age 53 years; 47% women) were enrolled. According to fibrosis-4 index, 64%, 26%, and 10% of the patients had no significant fibrosis, indeterminate stage, and advanced fibrosis, respectively. Patients with advanced fib…

NAFLD non-alcoholic fatty liver diseasemedicine.medical_specialtyBMI body mass indexNASH non-alcoholic steatohepatitisLiver fibrosisLSM liver stiffness measurementAST aspartate aminotransferaseLiver diseaseFLAG Fatty Liver Assessment in GermanyNAFLDALT alanine aminotransferaseInternal medicineAPRI aspartate-aminotransferase-to-platelet ratio indexInternal MedicineNAFL non-alcoholic fatty liverImmunology and AllergyMedicineddc:610Co-morbiditieslcsh:RC799-869FIB-4 fibrosis-4Disease burdenHepatologyFAST FibroScan-ASTGGT gamma-glutamyltransferasebusiness.industryFatty liverNASHGastroenterologyReal worldGLP-1 glucagon-like peptide-1T2DM type 2 diabetes mellitusCVE cardiovascular eventmedicine.diseaseMetabolic syndromeCohortlcsh:Diseases of the digestive system. GastroenterologyCAP controlled attenuation parameterSteatohepatitisMetabolic syndromebusinessBody mass indexResearch ArticleCohort studyJHEP Reports
researchProduct

Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis

2021

Background & Aims Progressive fibrosis has been identified as the major predictor of mortality in patients with non-alcoholic fatty liver disease (NAFLD). Several biomarkers are currently being evaluated for their ability to substitute the liver biopsy as the reference standard. Recent clinical studies in NAFLD/NASH patients support the utility of PRO-C3, a marker of type III collagen formation, as a marker for the degree of fibrosis, disease activity, and effect of treatment. Here we establish the healthy reference range, optimal sample handling conditions for both short- and long-term serum storage, and robustness for the PRO-C3 assay. Methods PRO-C3 was measured in 269 healthy volunteers…

NASH-CRN NASH Clinical Research NetworkBiopsyDiseaseAST aspartate aminotransferaseRC799-869Ethnic groupsGastroenterologyNIMBLE Non-Invasive Biomarkers of Metabolic Liver Disease (consortium)FibrosisImmunology and AllergyBody mass indexmedicine.diagnostic_testFatty liverNAS NAFLD Activity ScoreGastroenterologyDiseases of the digestive system. GastroenterologyHospitalsNPV negative predictive valueLiver biopsyBiomarker (medicine)Research Articlemedicine.medical_specialtyNAFLD non-alcoholic fatty liver diseaseADAM A Disintegrin and MetalloproteasesNASH non-alcoholic steatohepatitisReference rangeReference valuesAUROC area under the receiver operating characteristics curveInternal medicineALT alanine aminotransferaseBiopsyInternal MedicinemedicineHumansFIB-4 fibrosis-4Healthy volunteersHepatologyALP alkaline phosphatasebusiness.industryCLSI Clinical and Laboratory Standards InstituteT2DM type 2 diabetes mellitusELF™ test Enhanced Liver Fibrosis testmedicine.diseaseLITMUS Liver Investigation: Testing Marker Utility in Steatohepatitis (consortium)Collagen type IIIFibrosisPPV positive predictive valueReference standardsbusinessBody mass indexBiomarkersNon-alcoholic fatty liver disease
researchProduct

Fullerene as a Platform for Recyclable TEMPO Organocatalysts for the Oxidation of Alcohols

2014

[60]Fullerene has been employed successfully as a molecular platform to anchor 12 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) moieties. Such an octahedrally substituted C60-derivative has been employed as an organocatalyst for the oxidation of primary and secondary alcohols using the Anelli protocol. The reaction showed a general applicability to various alcohols, and the catalyst was recovered easily and could be recycled for at least seven cycles with no loss in catalytic activity. EPR spectroscopy studies revealed that the amount of radicals decreases during the catalytic cycles, even if the recovered material still displays unchanged catalytic activity. This new approach paves the way …

NITROXIDEFullerenePrimary (chemistry)alcoholoxidationChemistryCATALYSISRadicalOrganic ChemistrySettore CHIM/06 - Chimica Organicaorganocatalysiorganic oxidationlaw.inventionCatalysisInorganic ChemistrylawAlcohol oxidationOrganocatalysisOrganic chemistryPhysical and Theoretical ChemistryTEMPOElectron paramagnetic resonanceFULLERENEEPR spectroscopyESR
researchProduct

NUOVE STRATEGIE TERAPEUTICHE E DIAGNOSTICHE PER IL MANAGEMENT DEL RISCHIO CARDIO-METABOLICO IN PAZIENTI CON NAFLD CON O SENZA DIABETE MELLITO TIPO 2

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DIABETE MELLITO TIPO 2 (DMT2) TERAPIE INNOVATIVE SMALL DENSE LOW DENSITY LIPOPROTEIN (sdLDL) PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) RISCHIO CARDIOVASCOLARE
researchProduct